Literature DB >> 17572497

Update on bacterial conjunctivitis in South Florida.

Kara Cavuoto1, Deepti Zutshi, Carol L Karp, Darlene Miller, William Feuer.   

Abstract

PURPOSE: To report demographics, organism occurrence, and in vitro resistance trends for patients presenting with bacterial conjunctivitis at Bascom Palmer Eye Institute in Miami, Florida from 1994 to 2003.
DESIGN: Retrospective cross-sectional study. PARTICIPANTS: Two thousand four hundred eight eyes.
METHODS: The microbiology records of all patients with bacterial conjunctivitis seeking treatment at Bascom Palmer Eye Institute from January 1, 1994 through December 31, 2003 were reviewed. Data on age, gender, culture-positive trends, and in vitro susceptibility were collected. In vitro susceptibility data were generated using disc diffusion and minimal inhibitory concentrations. MAIN OUTCOME MEASURES: Positive cultures by age, gender, and organism and in vitro resistance.
RESULTS: During the 10-year period, 1254 culture-positive pathogens were recovered from 2408 consecutive conjunctival swabs (52.1%). The culture-positive rate from 1994 to 1998 was 55% and declined to 44% in the second 5 years. Male and female patients contributed equal percentages to the total isolates (50.0%). Females had a higher percentage of gram-positives than males (55.5%; P = 0.033). Gram-positive pathogens accounted for 52.2% of culture positive isolates. Staphylococcus aureus was the most frequent isolate overall (37.6%) and in patients older than 6 years (47.8%). Methicillin-resistant S. aureus showed a significant increase in the 10-year period (4.4%-42.9% of S. aureus isolates; P = 0.001). Haemophilus influenzae was the most frequent isolate recovered from patients under 7 years old (59.8%; P = 0.0002). There was a 3-fold increase in resistance of gram-positives to ciprofloxacin and oxacillin (P = 0.001). Overall, 9.5% of gram-positive isolates were resistant to gentamicin. Trimethoprim/sulfa showed a steady increase in resistance in gram-negative isolates (P = 0.05).
CONCLUSIONS: Staphylococcus aureus was the most common pathogen isolated. Methicillin-resistant S. aureus showed significant increasing prevalence. There were 2- and 3-fold increases in resistance of gram-positive organisms to erythromycin and ciprofloxacin, respectively. Gentamicin showed good sensitivity toward gram-positive pathogens.

Entities:  

Mesh:

Year:  2007        PMID: 17572497     DOI: 10.1016/j.ophtha.2007.03.076

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  36 in total

1.  Shifting trends in in vitro antibiotic susceptibilities for common bacterial conjunctival isolates in the last decade at the New York Eye and Ear Infirmary.

Authors:  Adebukola Adebayo; Jignesh G Parikh; Steven A McCormick; Mahendra K Shah; Remedios S Huerto; Guopei Yu; Tatyana Milman
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2010-06-08       Impact factor: 3.117

2.  Microbiology and visual outcomes of culture-positive bacterial endophthalmitis in Oxford, UK.

Authors:  A Gupta; H O Orlans; S J Hornby; I C J W Bowler
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2014-06-11       Impact factor: 3.117

3.  Besifloxacin ophthalmic suspension 0.6% administered twice daily for 3 days in the treatment of bacterial conjunctivitis in adults and children.

Authors:  Jesse DeLeon; Bruce E Silverstein; Catherine Allaire; Lynne S Gearinger; Kirk M Bateman; Timothy W Morris; Timothy L Comstock
Journal:  Clin Drug Investig       Date:  2012-05-01       Impact factor: 2.859

4.  Safety and tolerability of besifloxacin ophthalmic suspension 0.6% in the treatment of bacterial conjunctivitis: data from six clinical and phase I safety studies.

Authors:  Timothy L Comstock; Michael R Paterno; Heleen H Decory; Dale W Usner
Journal:  Clin Drug Investig       Date:  2010       Impact factor: 2.859

5.  The role of topical moxifloxacin, a new antibacterial in Europe, in the treatment of bacterial conjunctivitis.

Authors:  Jose Benitez-Del-Castillo; Yves Verboven; David Stroman; Laurent Kodjikian
Journal:  Clin Drug Investig       Date:  2011       Impact factor: 2.859

6.  Characterization of ocular methicillin-resistant Staphylococcus epidermidis isolates belonging predominantly to clonal complex 2 subcluster II.

Authors:  Paulo J M Bispo; Ana Luisa Hofling-Lima; Antonio C C Pignatari
Journal:  J Clin Microbiol       Date:  2014-02-12       Impact factor: 5.948

7.  Besifloxacin: a novel anti-infective for the treatment of bacterial conjunctivitis.

Authors:  Timothy L Comstock; Paul M Karpecki; Timothy W Morris; Jin-Zhong Zhang
Journal:  Clin Ophthalmol       Date:  2010-04-26

8.  Trends in antibiotic resistance in bacterial keratitis isolates from South India.

Authors:  Prajna Lalitha; Geetha Manoharan; Rajaram Karpagam; Namperumalsamy V Prajna; Muthiah Srinivasan; Jeena Mascarenhas; Manoranjan Das; Travis C Porco; Thomas M Lietman; Vicky Cevallos; Jeremy D Keenan
Journal:  Br J Ophthalmol       Date:  2016-04-29       Impact factor: 4.638

9.  Influence of lipopolysaccharide on proinflammatory gene expression in human corneal, conjunctival and meibomian gland epithelial cells.

Authors:  Di Chen; Afsun Sahin; Wendy R Kam; Yang Liu; Raheleh Rahimi Darabad; David A Sullivan
Journal:  Ocul Surf       Date:  2018-05-31       Impact factor: 5.033

10.  Impact of antibiotic resistance in the management of ocular infections: the role of current and future antibiotics.

Authors:  Joseph S Bertino
Journal:  Clin Ophthalmol       Date:  2009-09-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.